nodes	percent_of_prediction	percent_of_DWPC	metapath
Colistimethate—Dysarthria—Doxorubicin—kidney cancer	0.00148	0.00148	CcSEcCtD
Colistimethate—Musculoskeletal discomfort—Erlotinib—kidney cancer	0.00148	0.00148	CcSEcCtD
Colistimethate—Blood creatinine increased—Capecitabine—kidney cancer	0.00148	0.00148	CcSEcCtD
Colistimethate—Creatinine increased—Doxorubicin—kidney cancer	0.00147	0.00147	CcSEcCtD
Colistimethate—Decreased appetite—Vinblastine—kidney cancer	0.00147	0.00147	CcSEcCtD
Colistimethate—Chest pain—Sunitinib—kidney cancer	0.00147	0.00147	CcSEcCtD
Colistimethate—Arthralgia—Sunitinib—kidney cancer	0.00147	0.00147	CcSEcCtD
Colistimethate—Mental disorder—Vincristine—kidney cancer	0.00147	0.00147	CcSEcCtD
Colistimethate—Decreased appetite—Everolimus—kidney cancer	0.00146	0.00146	CcSEcCtD
Colistimethate—Diarrhoea—Pazopanib—kidney cancer	0.00146	0.00146	CcSEcCtD
Colistimethate—Gastrointestinal disorder—Everolimus—kidney cancer	0.00145	0.00145	CcSEcCtD
Colistimethate—Fatigue—Everolimus—kidney cancer	0.00145	0.00145	CcSEcCtD
Colistimethate—Dyspnoea—Erlotinib—kidney cancer	0.00145	0.00145	CcSEcCtD
Colistimethate—Vomiting—Temsirolimus—kidney cancer	0.00144	0.00144	CcSEcCtD
Colistimethate—Immune system disorder—Gemcitabine—kidney cancer	0.00143	0.00143	CcSEcCtD
Colistimethate—Nervous system disorder—Sorafenib—kidney cancer	0.00143	0.00143	CcSEcCtD
Colistimethate—Mediastinal disorder—Gemcitabine—kidney cancer	0.00143	0.00143	CcSEcCtD
Colistimethate—Rash—Temsirolimus—kidney cancer	0.00143	0.00143	CcSEcCtD
Colistimethate—Dermatitis—Temsirolimus—kidney cancer	0.00143	0.00143	CcSEcCtD
Colistimethate—Headache—Temsirolimus—kidney cancer	0.00142	0.00142	CcSEcCtD
Colistimethate—Decreased appetite—Erlotinib—kidney cancer	0.00141	0.00141	CcSEcCtD
Colistimethate—Dizziness—Pazopanib—kidney cancer	0.00141	0.00141	CcSEcCtD
Colistimethate—Gastrointestinal disorder—Erlotinib—kidney cancer	0.0014	0.0014	CcSEcCtD
Colistimethate—Fatigue—Erlotinib—kidney cancer	0.0014	0.0014	CcSEcCtD
Colistimethate—Epistaxis—Paclitaxel—kidney cancer	0.0014	0.0014	CcSEcCtD
Colistimethate—Nervous system disorder—Sunitinib—kidney cancer	0.00138	0.00138	CcSEcCtD
Colistimethate—Asthma—Capecitabine—kidney cancer	0.00136	0.00136	CcSEcCtD
Colistimethate—Salivary hypersecretion—Doxorubicin—kidney cancer	0.00136	0.00136	CcSEcCtD
Colistimethate—Vomiting—Pazopanib—kidney cancer	0.00136	0.00136	CcSEcCtD
Colistimethate—Rash—Pazopanib—kidney cancer	0.00134	0.00134	CcSEcCtD
Colistimethate—Nausea—Temsirolimus—kidney cancer	0.00134	0.00134	CcSEcCtD
Colistimethate—Dermatitis—Pazopanib—kidney cancer	0.00134	0.00134	CcSEcCtD
Colistimethate—Bronchospasm—Capecitabine—kidney cancer	0.00134	0.00134	CcSEcCtD
Colistimethate—Candida infection—Doxorubicin—kidney cancer	0.00134	0.00134	CcSEcCtD
Colistimethate—Headache—Pazopanib—kidney cancer	0.00134	0.00134	CcSEcCtD
Colistimethate—Musculoskeletal discomfort—Sorafenib—kidney cancer	0.00133	0.00133	CcSEcCtD
Colistimethate—Body temperature increased—Everolimus—kidney cancer	0.00133	0.00133	CcSEcCtD
Colistimethate—Blood urea increased—Doxorubicin—kidney cancer	0.00132	0.00132	CcSEcCtD
Colistimethate—Urinary tract disorder—Paclitaxel—kidney cancer	0.00131	0.00131	CcSEcCtD
Colistimethate—Vertigo—Vincristine—kidney cancer	0.00131	0.00131	CcSEcCtD
Colistimethate—Abdominal discomfort—Capecitabine—kidney cancer	0.00131	0.00131	CcSEcCtD
Colistimethate—Connective tissue disorder—Paclitaxel—kidney cancer	0.00131	0.00131	CcSEcCtD
Colistimethate—Urethral disorder—Paclitaxel—kidney cancer	0.0013	0.0013	CcSEcCtD
Colistimethate—Dyspnoea—Sorafenib—kidney cancer	0.0013	0.0013	CcSEcCtD
Colistimethate—Body temperature increased—Erlotinib—kidney cancer	0.00128	0.00128	CcSEcCtD
Colistimethate—Musculoskeletal discomfort—Sunitinib—kidney cancer	0.00128	0.00128	CcSEcCtD
Colistimethate—Decreased appetite—Sorafenib—kidney cancer	0.00127	0.00127	CcSEcCtD
Colistimethate—Nausea—Pazopanib—kidney cancer	0.00127	0.00127	CcSEcCtD
Colistimethate—Paraesthesia—Sunitinib—kidney cancer	0.00126	0.00126	CcSEcCtD
Colistimethate—Convulsion—Vincristine—kidney cancer	0.00126	0.00126	CcSEcCtD
Colistimethate—Gastrointestinal disorder—Sorafenib—kidney cancer	0.00126	0.00126	CcSEcCtD
Colistimethate—Fatigue—Sorafenib—kidney cancer	0.00126	0.00126	CcSEcCtD
Colistimethate—Dyspnoea—Sunitinib—kidney cancer	0.00125	0.00125	CcSEcCtD
Colistimethate—Hypersensitivity—Vinblastine—kidney cancer	0.00125	0.00125	CcSEcCtD
Colistimethate—Hypersensitivity—Everolimus—kidney cancer	0.00124	0.00124	CcSEcCtD
Colistimethate—Tinnitus—Paclitaxel—kidney cancer	0.00124	0.00124	CcSEcCtD
Colistimethate—Decreased appetite—Sunitinib—kidney cancer	0.00122	0.00122	CcSEcCtD
Colistimethate—Gastrointestinal disorder—Sunitinib—kidney cancer	0.00121	0.00121	CcSEcCtD
Colistimethate—Musculoskeletal discomfort—Dactinomycin—kidney cancer	0.00121	0.00121	CcSEcCtD
Colistimethate—Asthenia—Vinblastine—kidney cancer	0.00121	0.00121	CcSEcCtD
Colistimethate—Fatigue—Sunitinib—kidney cancer	0.00121	0.00121	CcSEcCtD
Colistimethate—Asthenia—Everolimus—kidney cancer	0.00121	0.00121	CcSEcCtD
Colistimethate—Cough—Gemcitabine—kidney cancer	0.00121	0.00121	CcSEcCtD
Colistimethate—Immune system disorder—Paclitaxel—kidney cancer	0.0012	0.0012	CcSEcCtD
Colistimethate—Mediastinal disorder—Paclitaxel—kidney cancer	0.0012	0.0012	CcSEcCtD
Colistimethate—Arthralgia—Gemcitabine—kidney cancer	0.00118	0.00118	CcSEcCtD
Colistimethate—Chest pain—Gemcitabine—kidney cancer	0.00118	0.00118	CcSEcCtD
Colistimethate—Nervous system disorder—Vincristine—kidney cancer	0.00117	0.00117	CcSEcCtD
Colistimethate—Asthenia—Erlotinib—kidney cancer	0.00117	0.00117	CcSEcCtD
Colistimethate—Mental disorder—Paclitaxel—kidney cancer	0.00117	0.00117	CcSEcCtD
Colistimethate—Urticaria—Sorafenib—kidney cancer	0.00116	0.00116	CcSEcCtD
Colistimethate—Malnutrition—Paclitaxel—kidney cancer	0.00116	0.00116	CcSEcCtD
Colistimethate—Decreased appetite—Dactinomycin—kidney cancer	0.00116	0.00116	CcSEcCtD
Colistimethate—Diarrhoea—Vinblastine—kidney cancer	0.00116	0.00116	CcSEcCtD
Colistimethate—Body temperature increased—Sorafenib—kidney cancer	0.00116	0.00116	CcSEcCtD
Colistimethate—Diarrhoea—Everolimus—kidney cancer	0.00115	0.00115	CcSEcCtD
Colistimethate—Fatigue—Dactinomycin—kidney cancer	0.00115	0.00115	CcSEcCtD
Colistimethate—Epistaxis—Capecitabine—kidney cancer	0.00115	0.00115	CcSEcCtD
Colistimethate—Flatulence—Paclitaxel—kidney cancer	0.00114	0.00114	CcSEcCtD
Colistimethate—Dysgeusia—Paclitaxel—kidney cancer	0.00113	0.00113	CcSEcCtD
Colistimethate—Dizziness—Vinblastine—kidney cancer	0.00112	0.00112	CcSEcCtD
Colistimethate—Dizziness—Everolimus—kidney cancer	0.00111	0.00111	CcSEcCtD
Colistimethate—Body temperature increased—Sunitinib—kidney cancer	0.00111	0.00111	CcSEcCtD
Colistimethate—Diarrhoea—Erlotinib—kidney cancer	0.00111	0.00111	CcSEcCtD
Colistimethate—Nervous system disorder—Gemcitabine—kidney cancer	0.00111	0.00111	CcSEcCtD
Colistimethate—Musculoskeletal discomfort—Vincristine—kidney cancer	0.00108	0.00108	CcSEcCtD
Colistimethate—Urinary tract disorder—Capecitabine—kidney cancer	0.00108	0.00108	CcSEcCtD
Colistimethate—Hypersensitivity—Sorafenib—kidney cancer	0.00108	0.00108	CcSEcCtD
Colistimethate—Vomiting—Vinblastine—kidney cancer	0.00107	0.00107	CcSEcCtD
Colistimethate—Dizziness—Erlotinib—kidney cancer	0.00107	0.00107	CcSEcCtD
Colistimethate—Connective tissue disorder—Capecitabine—kidney cancer	0.00107	0.00107	CcSEcCtD
Colistimethate—Vomiting—Everolimus—kidney cancer	0.00107	0.00107	CcSEcCtD
Colistimethate—Urethral disorder—Capecitabine—kidney cancer	0.00107	0.00107	CcSEcCtD
Colistimethate—Paraesthesia—Vincristine—kidney cancer	0.00107	0.00107	CcSEcCtD
Colistimethate—Rash—Everolimus—kidney cancer	0.00106	0.00106	CcSEcCtD
Colistimethate—Dermatitis—Everolimus—kidney cancer	0.00106	0.00106	CcSEcCtD
Colistimethate—Headache—Vinblastine—kidney cancer	0.00106	0.00106	CcSEcCtD
Colistimethate—Headache—Everolimus—kidney cancer	0.00106	0.00106	CcSEcCtD
Colistimethate—Body temperature increased—Dactinomycin—kidney cancer	0.00105	0.00105	CcSEcCtD
Colistimethate—Asthenia—Sorafenib—kidney cancer	0.00105	0.00105	CcSEcCtD
Colistimethate—Vertigo—Paclitaxel—kidney cancer	0.00104	0.00104	CcSEcCtD
Colistimethate—Hypersensitivity—Sunitinib—kidney cancer	0.00104	0.00104	CcSEcCtD
Colistimethate—Decreased appetite—Vincristine—kidney cancer	0.00103	0.00103	CcSEcCtD
Colistimethate—Vomiting—Erlotinib—kidney cancer	0.00103	0.00103	CcSEcCtD
Colistimethate—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.00103	0.00103	CcSEcCtD
Colistimethate—Gastrointestinal disorder—Vincristine—kidney cancer	0.00103	0.00103	CcSEcCtD
Colistimethate—Fatigue—Vincristine—kidney cancer	0.00103	0.00103	CcSEcCtD
Colistimethate—Rash—Erlotinib—kidney cancer	0.00102	0.00102	CcSEcCtD
Colistimethate—Dermatitis—Erlotinib—kidney cancer	0.00102	0.00102	CcSEcCtD
Colistimethate—Headache—Erlotinib—kidney cancer	0.00102	0.00102	CcSEcCtD
Colistimethate—Tinnitus—Capecitabine—kidney cancer	0.00102	0.00102	CcSEcCtD
Colistimethate—Paraesthesia—Gemcitabine—kidney cancer	0.00101	0.00101	CcSEcCtD
Colistimethate—Cough—Paclitaxel—kidney cancer	0.00101	0.00101	CcSEcCtD
Colistimethate—Asthenia—Sunitinib—kidney cancer	0.00101	0.00101	CcSEcCtD
Colistimethate—Dyspnoea—Gemcitabine—kidney cancer	0.00101	0.00101	CcSEcCtD
Colistimethate—Nausea—Vinblastine—kidney cancer	0.001	0.001	CcSEcCtD
Colistimethate—Somnolence—Gemcitabine—kidney cancer	0.001	0.001	CcSEcCtD
Colistimethate—Convulsion—Paclitaxel—kidney cancer	0.001	0.001	CcSEcCtD
Colistimethate—Nausea—Everolimus—kidney cancer	0.001	0.001	CcSEcCtD
Colistimethate—Diarrhoea—Sorafenib—kidney cancer	0.001	0.001	CcSEcCtD
Colistimethate—Immune system disorder—Capecitabine—kidney cancer	0.000986	0.000986	CcSEcCtD
Colistimethate—Arthralgia—Paclitaxel—kidney cancer	0.000986	0.000986	CcSEcCtD
Colistimethate—Chest pain—Paclitaxel—kidney cancer	0.000986	0.000986	CcSEcCtD
Colistimethate—Mediastinal disorder—Capecitabine—kidney cancer	0.000984	0.000984	CcSEcCtD
Colistimethate—Anxiety—Paclitaxel—kidney cancer	0.000982	0.000982	CcSEcCtD
Colistimethate—Decreased appetite—Gemcitabine—kidney cancer	0.000981	0.000981	CcSEcCtD
Colistimethate—Hypersensitivity—Dactinomycin—kidney cancer	0.000981	0.000981	CcSEcCtD
Colistimethate—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000974	0.000974	CcSEcCtD
Colistimethate—Fatigue—Gemcitabine—kidney cancer	0.000973	0.000973	CcSEcCtD
Colistimethate—Dizziness—Sorafenib—kidney cancer	0.000967	0.000967	CcSEcCtD
Colistimethate—Nausea—Erlotinib—kidney cancer	0.000965	0.000965	CcSEcCtD
Colistimethate—Diarrhoea—Sunitinib—kidney cancer	0.000962	0.000962	CcSEcCtD
Colistimethate—Mental disorder—Capecitabine—kidney cancer	0.000956	0.000956	CcSEcCtD
Colistimethate—Asthenia—Dactinomycin—kidney cancer	0.000955	0.000955	CcSEcCtD
Colistimethate—Blood creatinine increased—Doxorubicin—kidney cancer	0.000953	0.000953	CcSEcCtD
Colistimethate—Malnutrition—Capecitabine—kidney cancer	0.00095	0.00095	CcSEcCtD
Colistimethate—Body temperature increased—Vincristine—kidney cancer	0.000941	0.000941	CcSEcCtD
Colistimethate—Flatulence—Capecitabine—kidney cancer	0.000936	0.000936	CcSEcCtD
Colistimethate—Dysgeusia—Capecitabine—kidney cancer	0.000931	0.000931	CcSEcCtD
Colistimethate—Dizziness—Sunitinib—kidney cancer	0.00093	0.00093	CcSEcCtD
Colistimethate—Vomiting—Sorafenib—kidney cancer	0.000929	0.000929	CcSEcCtD
Colistimethate—Nervous system disorder—Paclitaxel—kidney cancer	0.000927	0.000927	CcSEcCtD
Colistimethate—Rash—Sorafenib—kidney cancer	0.000922	0.000922	CcSEcCtD
Colistimethate—Dermatitis—Sorafenib—kidney cancer	0.000921	0.000921	CcSEcCtD
Colistimethate—Headache—Sorafenib—kidney cancer	0.000916	0.000916	CcSEcCtD
Colistimethate—Diarrhoea—Dactinomycin—kidney cancer	0.000911	0.000911	CcSEcCtD
Colistimethate—Vomiting—Sunitinib—kidney cancer	0.000894	0.000894	CcSEcCtD
Colistimethate—Body temperature increased—Gemcitabine—kidney cancer	0.000892	0.000892	CcSEcCtD
Colistimethate—Rash—Sunitinib—kidney cancer	0.000887	0.000887	CcSEcCtD
Colistimethate—Dermatitis—Sunitinib—kidney cancer	0.000886	0.000886	CcSEcCtD
Colistimethate—Headache—Sunitinib—kidney cancer	0.000881	0.000881	CcSEcCtD
Colistimethate—Asthma—Doxorubicin—kidney cancer	0.000879	0.000879	CcSEcCtD
Colistimethate—Hypersensitivity—Vincristine—kidney cancer	0.000877	0.000877	CcSEcCtD
Colistimethate—Nausea—Sorafenib—kidney cancer	0.000868	0.000868	CcSEcCtD
Colistimethate—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000861	0.000861	CcSEcCtD
Colistimethate—Vertigo—Capecitabine—kidney cancer	0.000854	0.000854	CcSEcCtD
Colistimethate—Asthenia—Vincristine—kidney cancer	0.000854	0.000854	CcSEcCtD
Colistimethate—Paraesthesia—Paclitaxel—kidney cancer	0.000849	0.000849	CcSEcCtD
Colistimethate—Vomiting—Dactinomycin—kidney cancer	0.000847	0.000847	CcSEcCtD
Colistimethate—Dyspnoea—Paclitaxel—kidney cancer	0.000843	0.000843	CcSEcCtD
Colistimethate—Somnolence—Paclitaxel—kidney cancer	0.00084	0.00084	CcSEcCtD
Colistimethate—Rash—Dactinomycin—kidney cancer	0.00084	0.00084	CcSEcCtD
Colistimethate—Nausea—Sunitinib—kidney cancer	0.000836	0.000836	CcSEcCtD
Colistimethate—Cough—Capecitabine—kidney cancer	0.000829	0.000829	CcSEcCtD
Colistimethate—Decreased appetite—Paclitaxel—kidney cancer	0.000821	0.000821	CcSEcCtD
Colistimethate—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000816	0.000816	CcSEcCtD
Colistimethate—Fatigue—Paclitaxel—kidney cancer	0.000815	0.000815	CcSEcCtD
Colistimethate—Diarrhoea—Vincristine—kidney cancer	0.000814	0.000814	CcSEcCtD
Colistimethate—Asthenia—Gemcitabine—kidney cancer	0.00081	0.00081	CcSEcCtD
Colistimethate—Chest pain—Capecitabine—kidney cancer	0.000809	0.000809	CcSEcCtD
Colistimethate—Arthralgia—Capecitabine—kidney cancer	0.000809	0.000809	CcSEcCtD
Colistimethate—Anxiety—Capecitabine—kidney cancer	0.000806	0.000806	CcSEcCtD
Colistimethate—Nausea—Dactinomycin—kidney cancer	0.000791	0.000791	CcSEcCtD
Colistimethate—Dizziness—Vincristine—kidney cancer	0.000787	0.000787	CcSEcCtD
Colistimethate—Diarrhoea—Gemcitabine—kidney cancer	0.000772	0.000772	CcSEcCtD
Colistimethate—Nervous system disorder—Capecitabine—kidney cancer	0.000761	0.000761	CcSEcCtD
Colistimethate—Vomiting—Vincristine—kidney cancer	0.000756	0.000756	CcSEcCtD
Colistimethate—Urticaria—Paclitaxel—kidney cancer	0.000751	0.000751	CcSEcCtD
Colistimethate—Rash—Vincristine—kidney cancer	0.00075	0.00075	CcSEcCtD
Colistimethate—Dermatitis—Vincristine—kidney cancer	0.000749	0.000749	CcSEcCtD
Colistimethate—Body temperature increased—Paclitaxel—kidney cancer	0.000747	0.000747	CcSEcCtD
Colistimethate—Headache—Vincristine—kidney cancer	0.000745	0.000745	CcSEcCtD
Colistimethate—Epistaxis—Doxorubicin—kidney cancer	0.000739	0.000739	CcSEcCtD
Colistimethate—Vomiting—Gemcitabine—kidney cancer	0.000718	0.000718	CcSEcCtD
Colistimethate—Rash—Gemcitabine—kidney cancer	0.000712	0.000712	CcSEcCtD
Colistimethate—Dermatitis—Gemcitabine—kidney cancer	0.000711	0.000711	CcSEcCtD
Colistimethate—Headache—Gemcitabine—kidney cancer	0.000707	0.000707	CcSEcCtD
Colistimethate—Nausea—Vincristine—kidney cancer	0.000707	0.000707	CcSEcCtD
Colistimethate—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000707	0.000707	CcSEcCtD
Colistimethate—Paraesthesia—Capecitabine—kidney cancer	0.000696	0.000696	CcSEcCtD
Colistimethate—Hypersensitivity—Paclitaxel—kidney cancer	0.000696	0.000696	CcSEcCtD
Colistimethate—Urinary tract disorder—Doxorubicin—kidney cancer	0.000695	0.000695	CcSEcCtD
Colistimethate—Connective tissue disorder—Doxorubicin—kidney cancer	0.000691	0.000691	CcSEcCtD
Colistimethate—Dyspnoea—Capecitabine—kidney cancer	0.000691	0.000691	CcSEcCtD
Colistimethate—Urethral disorder—Doxorubicin—kidney cancer	0.00069	0.00069	CcSEcCtD
Colistimethate—Asthenia—Paclitaxel—kidney cancer	0.000678	0.000678	CcSEcCtD
Colistimethate—Decreased appetite—Capecitabine—kidney cancer	0.000674	0.000674	CcSEcCtD
Colistimethate—Nausea—Gemcitabine—kidney cancer	0.00067	0.00067	CcSEcCtD
Colistimethate—Gastrointestinal disorder—Capecitabine—kidney cancer	0.00067	0.00067	CcSEcCtD
Colistimethate—Fatigue—Capecitabine—kidney cancer	0.000669	0.000669	CcSEcCtD
Colistimethate—Tinnitus—Doxorubicin—kidney cancer	0.000656	0.000656	CcSEcCtD
Colistimethate—Diarrhoea—Paclitaxel—kidney cancer	0.000647	0.000647	CcSEcCtD
Colistimethate—Immune system disorder—Doxorubicin—kidney cancer	0.000636	0.000636	CcSEcCtD
Colistimethate—Mediastinal disorder—Doxorubicin—kidney cancer	0.000634	0.000634	CcSEcCtD
Colistimethate—Dizziness—Paclitaxel—kidney cancer	0.000625	0.000625	CcSEcCtD
Colistimethate—Mental disorder—Doxorubicin—kidney cancer	0.000616	0.000616	CcSEcCtD
Colistimethate—Urticaria—Capecitabine—kidney cancer	0.000616	0.000616	CcSEcCtD
Colistimethate—Body temperature increased—Capecitabine—kidney cancer	0.000613	0.000613	CcSEcCtD
Colistimethate—Malnutrition—Doxorubicin—kidney cancer	0.000613	0.000613	CcSEcCtD
Colistimethate—Flatulence—Doxorubicin—kidney cancer	0.000604	0.000604	CcSEcCtD
Colistimethate—Vomiting—Paclitaxel—kidney cancer	0.000601	0.000601	CcSEcCtD
Colistimethate—Dysgeusia—Doxorubicin—kidney cancer	0.0006	0.0006	CcSEcCtD
Colistimethate—Rash—Paclitaxel—kidney cancer	0.000596	0.000596	CcSEcCtD
Colistimethate—Dermatitis—Paclitaxel—kidney cancer	0.000595	0.000595	CcSEcCtD
Colistimethate—Headache—Paclitaxel—kidney cancer	0.000592	0.000592	CcSEcCtD
Colistimethate—Hypersensitivity—Capecitabine—kidney cancer	0.000571	0.000571	CcSEcCtD
Colistimethate—Nausea—Paclitaxel—kidney cancer	0.000561	0.000561	CcSEcCtD
Colistimethate—Asthenia—Capecitabine—kidney cancer	0.000556	0.000556	CcSEcCtD
Colistimethate—Vertigo—Doxorubicin—kidney cancer	0.00055	0.00055	CcSEcCtD
Colistimethate—Cough—Doxorubicin—kidney cancer	0.000534	0.000534	CcSEcCtD
Colistimethate—Convulsion—Doxorubicin—kidney cancer	0.000531	0.000531	CcSEcCtD
Colistimethate—Diarrhoea—Capecitabine—kidney cancer	0.000531	0.000531	CcSEcCtD
Colistimethate—Arthralgia—Doxorubicin—kidney cancer	0.000521	0.000521	CcSEcCtD
Colistimethate—Chest pain—Doxorubicin—kidney cancer	0.000521	0.000521	CcSEcCtD
Colistimethate—Anxiety—Doxorubicin—kidney cancer	0.00052	0.00052	CcSEcCtD
Colistimethate—Dizziness—Capecitabine—kidney cancer	0.000513	0.000513	CcSEcCtD
Colistimethate—Vomiting—Capecitabine—kidney cancer	0.000493	0.000493	CcSEcCtD
Colistimethate—Nervous system disorder—Doxorubicin—kidney cancer	0.00049	0.00049	CcSEcCtD
Colistimethate—Rash—Capecitabine—kidney cancer	0.000489	0.000489	CcSEcCtD
Colistimethate—Dermatitis—Capecitabine—kidney cancer	0.000489	0.000489	CcSEcCtD
Colistimethate—Headache—Capecitabine—kidney cancer	0.000486	0.000486	CcSEcCtD
Colistimethate—Nausea—Capecitabine—kidney cancer	0.000461	0.000461	CcSEcCtD
Colistimethate—Musculoskeletal discomfort—Doxorubicin—kidney cancer	0.000455	0.000455	CcSEcCtD
Colistimethate—Paraesthesia—Doxorubicin—kidney cancer	0.000449	0.000449	CcSEcCtD
Colistimethate—Dyspnoea—Doxorubicin—kidney cancer	0.000446	0.000446	CcSEcCtD
Colistimethate—Somnolence—Doxorubicin—kidney cancer	0.000444	0.000444	CcSEcCtD
Colistimethate—Decreased appetite—Doxorubicin—kidney cancer	0.000435	0.000435	CcSEcCtD
Colistimethate—Gastrointestinal disorder—Doxorubicin—kidney cancer	0.000432	0.000432	CcSEcCtD
Colistimethate—Fatigue—Doxorubicin—kidney cancer	0.000431	0.000431	CcSEcCtD
Colistimethate—Urticaria—Doxorubicin—kidney cancer	0.000397	0.000397	CcSEcCtD
Colistimethate—Body temperature increased—Doxorubicin—kidney cancer	0.000395	0.000395	CcSEcCtD
Colistimethate—Hypersensitivity—Doxorubicin—kidney cancer	0.000368	0.000368	CcSEcCtD
Colistimethate—Asthenia—Doxorubicin—kidney cancer	0.000359	0.000359	CcSEcCtD
Colistimethate—Diarrhoea—Doxorubicin—kidney cancer	0.000342	0.000342	CcSEcCtD
Colistimethate—Dizziness—Doxorubicin—kidney cancer	0.000331	0.000331	CcSEcCtD
Colistimethate—Vomiting—Doxorubicin—kidney cancer	0.000318	0.000318	CcSEcCtD
Colistimethate—Rash—Doxorubicin—kidney cancer	0.000315	0.000315	CcSEcCtD
Colistimethate—Dermatitis—Doxorubicin—kidney cancer	0.000315	0.000315	CcSEcCtD
Colistimethate—Headache—Doxorubicin—kidney cancer	0.000313	0.000313	CcSEcCtD
Colistimethate—Nausea—Doxorubicin—kidney cancer	0.000297	0.000297	CcSEcCtD
